A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes
Heather L Hondow1, Stephen B Fox, Gillian Mitchell
1Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Melbourne, Victoria, 8006, Australia.
BMC Cancer
|June 28, 2011
Summary
High-resolution melting (HRM) analysis offers a cost-effective method for screening BRCA1 and BRCA2 mutations. This optimized approach significantly reduces sequencing needs, making genetic testing more accessible.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- DNA sequencing mutation detection relies on laborious scanning methods requiring post-PCR manipulation.
- High-resolution melting (HRM) analysis is a rapid, cost-effective screening strategy for heterozygous variants.
- BRCA1 and BRCA2 germline pathogenic mutations are consistently heterozygous, making them suitable for HRM screening.
Purpose of the Study:
- To develop and optimize HRM assays for comprehensive screening of BRCA1 and BRCA2 coding regions and intron-exon boundaries.
- To establish a high-throughput, cost-effective method for detecting germline sequence variants in BRCA1 and BRCA2.
Main Methods:
- Designed and optimized 94 HRM assays (36 for BRCA1, 58 for BRCA2) for identical amplification conditions.
- Employed meticulous primer design, including deoxyinosine incorporation, to ensure reproducible mutation detection and minimize polymorphism interference.
- Utilized a multi-plate, 384-well format to facilitate high-throughput sample processing.
Main Results:
- Validated assays using 169 known BRCA1 and 239 BRCA2 sequence variants.
- Achieved 100% detection of all heterozygous variants in an extensive blinded validation with 384 patient DNAs.
- Demonstrated the efficiency of the optimized HRM protocol for accurate variant detection.
Conclusions:
- This study presents the first HRM approach for entire BRCA1 and BRCA2 coding region screening under unified conditions in a high-throughput format.
- The developed method significantly reduces the need for sequencing by over 90%, drastically lowering costs.
- This cost reduction is expected to increase the accessibility of BRCA1 and BRCA2 mutation testing for a wider population.


